Drug Type Biological products |
Synonyms GB23 |
Target |
Action modulators, agonists, inhibitors |
Mechanism GPC3 modulators(Glypican-3 modulators), IFN agonists(interferon alpha 1 agonists), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | China | 27 Apr 2024 |





